For example, PSVs in the BRCA1 and BRCA2 genes are associated with a significantly increased lifetime risk of developing breast and ovarian cancer, and in Israel, testing is offered only from the age of 25, when an early detection scheme in carrier women is being offered (https://www.nccn.org/guidelines/category_2). The gene discussed is BRCA2; the disease is ovarian cancer.